{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:09:43Z","timestamp":1793156983593,"version":"4.5.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a major global public health problem, and its occurrence is associated with adverse environmental exposures during development. In this study, we investigated the impact of the use of prednisone (a synthetic glucocorticoid drug) during pregnancy on susceptibility to MASLD in offspring and explored its potential therapeutic targets. Pregnant rodents were administered clinically equivalent doses of prednisone daily by oral gavage during gestation days (GDs) 0\u201320 in rats and GD0\u201318 mice, and their offspring were fed a high-fat diet from postnatal weeks 8\u201312. The results showed that prenatal prednisone exposure (PPE) led to reduced hepatic glucose uptake and fatty acid oxidation in offspring rats prenatally and postnatally and that the offspring developed more severe MASLD when fed a high-fat diet, with males exhibiting greater severity than females. Consistent findings were observed in PPE adult offspring mice. RNA-seq and experimental results revealed that hepatic Serpina3c expression was consistently reduced in PPE offspring before and after birth, which led to an increase in chymase-Ang II production and subsequent activation of its receptor AT1R, leading to MASLD susceptibility. In vivo and in vitro studies revealed that the programming of low Serpina3c expression was associated with reduced H3K27ac levels in the gene promoter region of Serpina3c caused by the activation of GR-HDAC3 signaling by the active metabolite prednisolone. Finally, postnatal high expression of hepatic Serpina3c reversed the activation of the chymase-Ang II-AT1R pathway and significantly ameliorated hepatic glucose and lipid metabolic dysfunction and MASLD susceptibility in PPE offspring. In summary, this study reveals MASLD susceptibility in offspring induced by PPE and identifies Serpina3c as a target for the prevention and treatment of MASLD susceptibility.<\/jats:p>","DOI":"10.1038\/s41392-025-02569-1","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:14:40Z","timestamp":1771398880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serpina3c protects against metabolic dysfunction-associated steatotic liver disease in offspring induced by prenatal prednisone exposure"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-5211","authenticated-orcid":false,"given":"Yongguo","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihemaitijiang","family":"Ailikaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanrui","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-1457","authenticated-orcid":false,"given":"Liaobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5300-8661","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"2569_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","volume":"191","author":"SE Andrade","year":"2004","unstructured":"Andrade, S. E. et al. Prescription drug use in pregnancy. Am. J. Obstet. Gynecol. 191, 398\u2013407 (2004).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2569_CR2","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/acr.21807","volume":"64","author":"K Palmsten","year":"2012","unstructured":"Palmsten, K., Hern\u00e1ndez-D\u00edaz, S., Kuriya, B., Solomon, D. H. & Setoguchi, S. Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia. Arthritis Care. Res. 64, 1730\u20131738 (2012).","journal-title":"Arthritis Care. Res."},{"key":"2569_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/AOG.0000000000000982","volume":"126","author":"K Palmsten","year":"2015","unstructured":"Palmsten, K. et al. The most commonly dispensed prescription medications among pregnant women enrolled in the U.S. Medicaid Program. Obstet. Gynecol. 126, 465\u2013473 (2015).","journal-title":"Obstet. Gynecol."},{"key":"2569_CR4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/art.24003","volume":"59","author":"YA de Man","year":"2008","unstructured":"de Man, Y. A., Dolhain, R. J., van de Geijn, F. E., Willemsen, S. P. & Hazes, J. M. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 59, 1241\u20131248 (2008).","journal-title":"Arthritis Rheum."},{"key":"2569_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/acr.20422","volume":"63","author":"B Kuriya","year":"2011","unstructured":"Kuriya, B. et al. Patterns of medication use during pregnancy in rheumatoid arthritis. Arthritis Care. Res. 63, 721\u2013728 (2011).","journal-title":"Arthritis Care. Res."},{"key":"2569_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/pds.4410","volume":"27","author":"K Palmsten","year":"2018","unstructured":"Palmsten, K. et al. Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: daily and cumulative dose. Pharmacoepidemiol. Drug Saf. 27, 430\u2013438 (2018).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"2569_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jri.2018.03.003","volume":"127","author":"N L\u00e9d\u00e9e","year":"2018","unstructured":"L\u00e9d\u00e9e, N. et al. Impact of prednisone in patients with repeated embryo implantation failures: beneficial or deleterious? J. Reprod. Immunol. 127, 11\u201315 (2018).","journal-title":"J. Reprod. Immunol."},{"key":"2569_CR8","doi-asserted-by":"publisher","first-page":"103369","DOI":"10.1016\/j.jri.2021.103369","volume":"148","author":"N Sung","year":"2021","unstructured":"Sung, N. et al. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment. J. Reprod. Immunol. 148, 103369 (2021).","journal-title":"J. Reprod. Immunol."},{"key":"2569_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.reprotox.2017.05.002","volume":"71","author":"FDO de Steenwinkel","year":"2017","unstructured":"de Steenwinkel, F. D. O., Dolhain, R., Hazes, J. M. W. & Hokken-Koelega, A. C. S. Does prednisone use or disease activity in pregnant women with rheumatoid arthritis influence the body composition of their offspring? Reprod. Toxicol. 71, 118\u2013123 (2017).","journal-title":"Reprod. Toxicol."},{"key":"2569_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10067-022-06347-0","volume":"42","author":"FDO de Steenwinkel","year":"2023","unstructured":"de Steenwinkel, F. D. O., Dolhain, R., Hazes, J. M. W. & Hokken-Koelega, A. C. S. Does prednisone use in pregnant women with rheumatoid arthritis induce insulin resistance in the offspring? Clin. Rheumatol. 42, 47\u201354 (2023).","journal-title":"Clin. Rheumatol."},{"key":"2569_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1590\/1806-9282.20220074","volume":"68","author":"DMJ Valviesse","year":"2022","unstructured":"Valviesse, D. M. J. et al. Risk factors associated with infections in pregnant women with systemic lupus erythematosus. Rev. Assoc. Med. Bras. 68, 536\u2013541 (2022).","journal-title":"Rev. Assoc. Med. Bras."},{"key":"2569_CR12","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jama.2023.5302","volume":"329","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Prednisone vs placebo and live birth in patients with recurrent implantation failure undergoing in vitro fertilization: a randomized clinical trial. JAMA 329, 1460\u20131468 (2023).","journal-title":"JAMA"},{"key":"2569_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","volume":"62","author":"L Park-Wyllie","year":"2000","unstructured":"Park-Wyllie, L. et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62, 385\u2013392 (2000).","journal-title":"Teratology"},{"key":"2569_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.705336","volume":"202","author":"JM Reinisch","year":"1978","unstructured":"Reinisch, J. M., Simon, N. G., Karow, W. G. & Gandelman, R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 202, 436\u2013438 (1978).","journal-title":"Science"},{"key":"2569_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/01.ju.0000139911.56346.1b","volume":"172","author":"S Yucel","year":"2004","unstructured":"Yucel, S., Desouza, A. & Baskin, L. S. In utero prednisone exposure affects genital development. J. Urol. 172, 1725\u20131730 (2004).","journal-title":"J. Urol."},{"key":"2569_CR16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/BF01939031","volume":"30","author":"HO Besedovsky","year":"1974","unstructured":"Besedovsky, H. O. Supression of fetal hematopoeitic development by prednisone treatment of pregnant rats. Experientia 30, 1098\u20131100 (1974).","journal-title":"Experientia"},{"key":"2569_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1203\/00006450-197710000-00003","volume":"11","author":"MC Romano","year":"1977","unstructured":"Romano, M. C., Gioia, I. A. & Bernasconi, M. V. Prednisone effects on postnatal brain development of rats following maternal therapy. Pediatr. Res. 11, 1042\u20131045 (1977).","journal-title":"Pediatr. Res."},{"key":"2569_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01148-8","volume":"16","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. Toxic effect window of ovarian development in female offspring mice induced by prenatal prednisone exposure with different doses and time. J. Ovarian Res. 16, 71 (2023).","journal-title":"J. Ovarian Res."},{"key":"2569_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jes.2023.09.042","volume":"145","author":"Z Xia","year":"2023","unstructured":"Xia, Z. et al. Prenatal prednisone exposure disturbs fetal kidney development and its characteristics. J. Environ. Sci. 145, 75\u201387 (2023).","journal-title":"J. Environ. Sci."},{"key":"2569_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.toxlet.2024.01.004","volume":"393","author":"J Xu","year":"2024","unstructured":"Xu, J. et al. Dose- and stage-dependent toxic effects of prenatal prednisone exposure on fetal articular cartilage development. Toxicol. Lett. 393, 14\u201323 (2024).","journal-title":"Toxicol. Lett."},{"key":"2569_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/toxsci\/kfae027","volume":"199","author":"Y Dai","year":"2024","unstructured":"Dai, Y. et al. Prenatal prednisone exposure impacts liver development and function in fetal mice and its characteristics. Toxicol. Sci. 199, 63\u201380 (2024).","journal-title":"Toxicol. Sci."},{"key":"2569_CR22","doi-asserted-by":"publisher","first-page":"133997","DOI":"10.1016\/j.jhazmat.2024.133997","volume":"469","author":"ZY Du","year":"2024","unstructured":"Du, Z. Y. et al. Maternal prednisone exposure during pregnancy elevates susceptibility to osteoporosis in female offspring: the role of mitophagy\/FNDC5 alteration in skeletal muscle. J. Hazard. Mater. 469, 133997 (2024).","journal-title":"J. Hazard. Mater."},{"key":"2569_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307442","volume":"11","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. Circular RNA Gtdc1 protects against offspring osteoarthritis induced by prenatal prednisone exposure by regulating SRSF1-Fn1 signaling. Adv. Sci. 11, e2307442 (2024).","journal-title":"Adv. Sci."},{"key":"2569_CR24","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542\u20131556 (2023).","journal-title":"J. Hepatol."},{"key":"2569_CR25","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81, 492\u2013542 (2024).."},{"key":"2569_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2569_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","volume":"122","author":"V Lekakis","year":"2023","unstructured":"Lekakis, V. & Papatheodoridis, G. V. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur. J. Intern. Med. 122, 3\u201310 (2023).","journal-title":"Eur. J. Intern. Med."},{"key":"2569_CR28","doi-asserted-by":"publisher","first-page":"9420002","DOI":"10.26599\/FMH.2024.9420002","volume":"1","author":"L Cao","year":"2024","unstructured":"Cao, L. et al. Cornus officinalis vinegar alters the gut microbiota, regulating lipid droplet changes in nonalcoholic fatty liver disease model mice. Food Med. Homol. 1, 9420002 (2024).","journal-title":"Food Med. Homol."},{"key":"2569_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jfutfo.2024.04.003","volume":"6","author":"J Li","year":"2026","unstructured":"Li, J. et al. Synergistic effect on nonalcoholic fatty liver disease by aptamer functionalized liposome loading allicin. J. Future Foods 6, 55\u201365 (2026).","journal-title":"J. Future Foods"},{"key":"2569_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3350\/cmh.2022.0239","volume":"28","author":"MH Le","year":"2022","unstructured":"Le, M. H. et al. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical Bayesian approach. Clin. Mol. Hepatol. 28, 841\u2013850 (2022).","journal-title":"Clin. Mol. Hepatol."},{"key":"2569_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1210\/en.2017-00887","volume":"159","author":"LS Trevi\u00f1o","year":"2018","unstructured":"Trevi\u00f1o, L. S. & Katz, T. A. Endocrine disruptors and developmental origins of nonalcoholic fatty liver disease. Endocrinology 159, 20\u201331 (2018).","journal-title":"Endocrinology"},{"key":"2569_CR32","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1152\/physrev.00002.2020","volume":"101","author":"DJ Hoffman","year":"2021","unstructured":"Hoffman, D. J., Powell, T. L., Barrett, E. S. & Hardy, D. B. Developmental origins of metabolic diseases. Physiol. Rev. 101, 739\u2013795 (2021).","journal-title":"Physiol. Rev."},{"key":"2569_CR33","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0022-3476(74)80109-5","volume":"85","author":"CJ Cot\u00e9","year":"1974","unstructured":"Cot\u00e9, C. J., Meuwissen, H. J. & Pickering, R. J. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J. Pediatr. 85, 324\u2013328 (1974).","journal-title":"J. Pediatr."},{"key":"2569_CR34","first-page":"241","volume":"6","author":"V Nobili","year":"2008","unstructured":"Nobili, V., Alisi, A., Panera, N. & Agostoni, C. Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. Pediatr. Endocrinol. Rev. 6, 241\u2013247 (2008).","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"2569_CR35","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/metabo12100886","volume":"12","author":"LS Almeida","year":"2022","unstructured":"Almeida, L. S. et al. Low birth weight intensifies changes in markers of hepatocarcinogenesis induced by fructose consumption in rats. Metabolites 12, 886 (2022).","journal-title":"Metabolites"},{"key":"2569_CR36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/ajg.2017.140","volume":"112","author":"E Bugianesi","year":"2017","unstructured":"Bugianesi, E. et al. Low birthweight increases the likelihood of severe steatosis in pediatric non-alcoholic fatty liver disease. Am. J. Gastroenterol. 112, 1277\u20131286 (2017).","journal-title":"Am. J. Gastroenterol."},{"key":"2569_CR37","first-page":"2588","volume":"25","author":"A Kammel","year":"2016","unstructured":"Kammel, A. et al. Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice. Hum. Mol. Genet. 25, 2588\u20132599 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"2569_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2337\/db15-1716","volume":"66","author":"C Baumeier","year":"2016","unstructured":"Baumeier, C. et al. Hepatic DPP4 DNA Methylation Associates With Fatty Liver. Diabetes 66, 25\u201335 (2016).","journal-title":"Diabetes"},{"key":"2569_CR39","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","volume":"62","author":"CJ Pirola","year":"2013","unstructured":"Pirola, C. J. et al. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 62, 1356\u20131363 (2013).","journal-title":"Gut"},{"key":"2569_CR40","doi-asserted-by":"publisher","first-page":"101111","DOI":"10.1016\/j.molmet.2020.101111","volume":"50","author":"W Jonas","year":"2021","unstructured":"Jonas, W. & Sch\u00fcrmann, A. Genetic and epigenetic factors determining NAFLD risk. Mol. Metab. 50, 101111 (2021).","journal-title":"Mol. Metab."},{"key":"2569_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","volume":"1253","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Lu, Q. & Chang, C. Epigenetics in health and disease. Adv. Exp. Med. Biol. 1253, 3\u201355 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2569_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/pr.2013.193","volume":"75","author":"DE Brumbaugh","year":"2014","unstructured":"Brumbaugh, D. E. & Friedman, J. E. Developmental origins of nonalcoholic fatty liver disease. Pediatr. Res. 75, 140\u2013147 (2014).","journal-title":"Pediatr. Res."},{"key":"2569_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155713","volume":"150","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. Glucocorticoids and intrauterine programming of nonalcoholic fatty liver disease. Metabolism 150, 155713 (2024).","journal-title":"Metabolism"},{"key":"2569_CR44","doi-asserted-by":"publisher","first-page":"18866","DOI":"10.1007\/s11356-019-05258-z","volume":"26","author":"D Li","year":"2019","unstructured":"Li, D. et al. Maternal exposure to perfluorooctanoic acid (PFOA) causes liver toxicity through PPAR-\u03b1 pathway and lowered histone acetylation in female offspring mice. Environ. Sci. Pollut. Res. Int. 26, 18866\u201318875 (2019).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"2569_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/JME-12-0046","volume":"49","author":"KF Yang","year":"2012","unstructured":"Yang, K. F., Cai, W., Xu, J. L. & Shi, W. Maternal high-fat diet programs Wnt genes through histone modification in the liver of neonatal rats. J. Mol. Endocrinol. 49, 107\u2013114 (2012).","journal-title":"J. Mol. Endocrinol."},{"key":"2569_CR46","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/jat.3502","volume":"37","author":"NE De Long","year":"2017","unstructured":"De Long, N. E., Hardy, D. B., Ma, N. & Holloway, A. C. Increased incidence of non-alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis. J. Appl. Toxicol. 37, 1507\u20131516 (2017).","journal-title":"J. Appl. Toxicol."},{"key":"2569_CR47","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1002\/jcp.29482","volume":"235","author":"MV Bariani","year":"2020","unstructured":"Bariani, M. V. et al. Maternal obesogenic diet combined with postnatal exposure to high-fat diet induces metabolic alterations in offspring. J. Cell. Physiol. 235, 8260\u20138269 (2020).","journal-title":"J. Cell. Physiol."},{"key":"2569_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01472-6","volume":"22","author":"H Xiao","year":"2024","unstructured":"Xiao, H. et al. Dexamethasone exposure during pregnancy triggers metabolic syndrome in offspring via epigenetic alteration of IGF1. Cell Commun. Signal. 22, 62 (2024).","journal-title":"Cell Commun. Signal."},{"key":"2569_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2013.12.010","volume":"275","author":"N Ma","year":"2014","unstructured":"Ma, N., Nicholson, C. J., Wong, M., Holloway, A. C. & Hardy, D. B. Fetal and neonatal exposure to nicotine leads to augmented hepatic and circulating triglycerides in adult male offspring due to increased expression of fatty acid synthase. Toxicol. Appl. Pharmacol. 275, 1\u201311 (2014).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2569_CR50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jnutbio.2014.10.009","volume":"26","author":"D Zhou","year":"2015","unstructured":"Zhou, D., Wang, H., Cui, H., Chen, H. & Pan, Y. X. Early-life exposure to high-fat diet may predispose rats to gender-specific hepatic fat accumulation by programming Pepck expression. J. Nutr. Biochem. 26, 433\u2013440 (2015).","journal-title":"J. Nutr. Biochem."},{"key":"2569_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tox.2019.02.008","volume":"417","author":"S Hu","year":"2019","unstructured":"Hu, S. et al. Prenatal caffeine exposure increases the susceptibility to non-alcoholic fatty liver disease in female offspring rats via activation of GR-C\/EBP\u03b1-SIRT1 pathway. Toxicology 417, 23\u201334 (2019).","journal-title":"Toxicology"},{"key":"2569_CR52","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.toxlet.2020.06.008","volume":"331","author":"W Hu","year":"2020","unstructured":"Hu, W. et al. Glucocorticoid-insulin-like growth factor 1 (GC-IGF1) axis programming mediated hepatic lipid-metabolic in offspring caused by prenatal ethanol exposure. Toxicol. Lett. 331, 167\u2013177 (2020).","journal-title":"Toxicol. Lett."},{"key":"2569_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.taap.2015.02.021","volume":"284","author":"RS Strakovsky","year":"2015","unstructured":"Strakovsky, R. S. et al. Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis. Toxicol. Appl. Pharmacol. 284, 101\u2013112 (2015).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2569_CR54","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1096\/fj.12-212878","volume":"26","author":"MA Suter","year":"2012","unstructured":"Suter, M. A. et al. A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. FASEB J. 26, 5106\u20135114 (2012).","journal-title":"FASEB J."},{"key":"2569_CR55","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1007\/s11427-023-2593-4","volume":"67","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Activation of the PGC-1\u03b1-mediated mitochondrial glutamine metabolism pathway attenuates female offspring osteoarthritis induced by prenatal excessive prednisone. Sci. China Life Sci. 67, 2382\u20132397 (2024).","journal-title":"Sci. China Life Sci."},{"key":"2569_CR56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s42255-024-01213-6","volume":"7","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Maternal exercise prevents metabolic disorders in offspring mice through SERPINA3C. Nat. Metab. 7, 401\u2013420 (2025).","journal-title":"Nat. Metab."},{"key":"2569_CR57","doi-asserted-by":"publisher","first-page":"1189007","DOI":"10.3389\/fendo.2023.1189007","volume":"14","author":"Y Li","year":"2023","unstructured":"Li, Y. & Guo, L. The versatile role of Serpina3c in physiological and pathological processes: a review of recent studies. Front. Endocrinol. 14, 1189007 (2023).","journal-title":"Front. Endocrinol."},{"key":"2569_CR58","doi-asserted-by":"publisher","first-page":"979995","DOI":"10.3389\/fimmu.2022.979995","volume":"13","author":"Z Fan","year":"2022","unstructured":"Fan, Z. et al. Immune-related SERPINA3 as a biomarker involved in diabetic nephropathy renal tubular injury. Front. Immunol. 13, 979995 (2022).","journal-title":"Front. Immunol."},{"key":"2569_CR59","doi-asserted-by":"publisher","first-page":"111119","DOI":"10.1016\/j.mce.2020.111119","volume":"529","author":"CM Ferrario","year":"2021","unstructured":"Ferrario, C. M. et al. The Angiotensin-(1-12)\/Chymase axis as an alternate component of the tissue renin angiotensin system. Mol. Cell Endocrinol. 529, 111119 (2021).","journal-title":"Mol. Cell Endocrinol."},{"key":"2569_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/liv.14272","volume":"40","author":"G Sanso\u00e8","year":"2020","unstructured":"Sanso\u00e8, G., Aragno, M. & Wong, F. Pathways of hepatic and renal damage through nonclassical activation of the renin-angiotensin system in chronic liver disease. Liver Int. 40, 18\u201331 (2020).","journal-title":"Liver Int."},{"key":"2569_CR61","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.kisu.2021.11.002","volume":"12","author":"CM Ferrario","year":"2022","unstructured":"Ferrario, C. M. et al. The renin-angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts. Kidney Int. Suppl. 12, 36\u201347 (2022).","journal-title":"Kidney Int. Suppl."},{"key":"2569_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijcard.2019.02.003","volume":"282","author":"A Brucato","year":"2019","unstructured":"Brucato, A. et al. Management of idiopathic recurrent pericarditis during pregnancy. Int. J. Cardiol. 282, 60\u201365 (2019).","journal-title":"Int. J. Cardiol."},{"key":"2569_CR63","first-page":"1067","volume":"39","author":"L Serati","year":"2023","unstructured":"Serati, L. et al. Pericardial diseases in pregnancy. Can. J. Cardiol. 39, 1067\u20131077 (2023).","journal-title":"Can. J. Cardiol."},{"key":"2569_CR64","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano, L. R. et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 72, 529\u2013556 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"2569_CR65","first-page":"412","volume":"38","author":"J Zhang","year":"2013","unstructured":"Zhang, J. & Zhang, N. Z. Aspirin combined with prednisone for treatment of recurrent spontaneous abortion. J. Bengbu Med. Coll. 38, 412\u2013414 (2013).","journal-title":"J. Bengbu Med. Coll."},{"key":"2569_CR66","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.wombi.2018.08.002","volume":"32","author":"D Zhang","year":"2019","unstructured":"Zhang, D., Zhang, L. & Wang, Z. The relationship between maternal weight gain in pregnancy and newborn weight. Women Birth 32, 270\u2013275 (2019).","journal-title":"Women Birth"},{"key":"2569_CR67","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/ppe.12704","volume":"34","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Nutrition in pregnancy and growth in Southwest China (NPGSC) cohort: design, implementation, and characteristics. Paediatr. Perinat. Epidemiol. 34, 724\u2013733 (2020).","journal-title":"Paediatr. Perinat. Epidemiol."},{"key":"2569_CR68","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijgo.2014.11.014","volume":"129","author":"W Jing","year":"2015","unstructured":"Jing, W. et al. The effect of a personalized intervention on weight gain and physical activity among pregnant women in China. Int. J. Gynecol. Obstet. 129, 138\u2013141 (2015).","journal-title":"Int. J. Gynecol. Obstet."},{"key":"2569_CR69","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659\u2013661 (2008).","journal-title":"FASEB J."},{"key":"2569_CR70","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ddr.21461","volume":"79","author":"A Nair","year":"2018","unstructured":"Nair, A., Morsy, M. A. & Jacob, S. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development. Drug Dev. Res. 79, 373\u2013382 (2018).","journal-title":"Drug Dev. Res."},{"key":"2569_CR71","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1017\/S0029665109001396","volume":"68","author":"S McMullen","year":"2009","unstructured":"McMullen, S. & Mostyn, A. Animal models for the study of the developmental origins of health and disease. Proc. Nutr. Soc. 68, 306\u2013320 (2009).","journal-title":"Proc. Nutr. Soc."},{"key":"2569_CR72","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/biomedicines9060623","volume":"9","author":"CN Hsu","year":"2021","unstructured":"Hsu, C. N. & Tain, Y. L. Animal models for DOHaD research: focus on hypertension of developmental origins. Biomedicines 9, 623 (2021).","journal-title":"Biomedicines"},{"key":"2569_CR73","doi-asserted-by":"publisher","first-page":"G99","DOI":"10.1152\/ajpgi.00168.2022","volume":"324","author":"DH Galvan-Martinez","year":"2023","unstructured":"Galvan-Martinez, D. H. et al. Nutritional, pharmacological, and environmental programming of NAFLD in early life. Am. J. Physiol. Gastrointest. Liver Physiol. 324, G99\u2013G114 (2023).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2569_CR74","doi-asserted-by":"publisher","first-page":"166889","DOI":"10.1016\/j.bbadis.2023.166889","volume":"1870","author":"R Wang","year":"2024","unstructured":"Wang, R. et al. Maternal obstructive sleep apnea aggravates metabolic dysfunction-associated fatty liver disease via HMGB1-TLR4 signaling-mediated endoplasmic reticulum stress in male offspring rats. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 166889 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"2569_CR75","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1530\/JOE-14-0356","volume":"222","author":"J Wei","year":"2014","unstructured":"Wei, J. et al. Perinatal exposure to bisphenol A exacerbates nonalcoholic steatohepatitis-like phenotype in male rat offspring fed on a high-fat diet. J. Endocrinol. 222, 313\u2013325 (2014).","journal-title":"J. Endocrinol."},{"key":"2569_CR76","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/19490976.2020.1738187","volume":"11","author":"X Dai","year":"2020","unstructured":"Dai, X. et al. Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood. Gut Microbes 11, 1043\u20131063 (2020).","journal-title":"Gut Microbes"},{"key":"2569_CR77","doi-asserted-by":"publisher","first-page":"109745","DOI":"10.1016\/j.cellsig.2020.109745","volume":"75","author":"JJ Ji","year":"2020","unstructured":"Ji, J. J. et al. Serpina3c protects against high-fat diet-induced pancreatic dysfunction through the JNK-related pathway. Cell Signal 75, 109745 (2020).","journal-title":"Cell Signal"},{"key":"2569_CR78","doi-asserted-by":"publisher","first-page":"110299","DOI":"10.1016\/j.cellsig.2022.110299","volume":"93","author":"J Guo","year":"2022","unstructured":"Guo, J. et al. Serpina3c regulates adipose differentiation via the Wnt\/\u03b2-catenin-PPAR\u03b3 pathway. Cell Signal 93, 110299 (2022).","journal-title":"Cell Signal"},{"key":"2569_CR79","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/CS20201235","volume":"135","author":"LL Qian","year":"2021","unstructured":"Qian, L. L. et al. Protective role of serpina3c as a novel thrombin inhibitor against atherosclerosis in mice. Clin. Sci. 135, 447\u2013463 (2021).","journal-title":"Clin. Sci."},{"key":"2569_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.100961","volume":"23","author":"Y Choi","year":"2020","unstructured":"Choi, Y. et al. Serpina3c regulates adipogenesis by modulating insulin growth factor 1 and integrin signaling. iScience 23, 100961 (2020).","journal-title":"iScience"},{"key":"2569_CR81","doi-asserted-by":"publisher","first-page":"101500","DOI":"10.1016\/j.molmet.2022.101500","volume":"61","author":"BY Li","year":"2022","unstructured":"Li, B. Y., Guo, Y. Y., Xiao, G., Guo, L. & Tang, Q. Q. SERPINA3C ameliorates adipose tissue inflammation through the Cathepsin G\/Integrin\/AKT pathway. Mol. Metab. 61, 101500 (2022).","journal-title":"Mol. Metab."},{"key":"2569_CR82","doi-asserted-by":"publisher","first-page":"498","DOI":"10.5606\/ArchRheumatol.2018.6595","volume":"33","author":"S Gao","year":"2018","unstructured":"Gao, S., Zhu, H., Zuo, X. & Luo, H. Cathepsin G and its role in inflammation and autoimmune diseases. Arch. Rheumatol. 33, 498\u2013504 (2018).","journal-title":"Arch. Rheumatol."},{"key":"2569_CR83","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1872-034X.2007.00271.x","volume":"38","author":"K Komeda","year":"2008","unstructured":"Komeda, K. et al. Significance of chymase-dependent angiotensin II formation in the progression of human liver fibrosis. Hepatol. Res. 38, 501\u2013510 (2008).","journal-title":"Hepatol. Res."},{"key":"2569_CR84","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/hep.21638","volume":"45","author":"A Hirose","year":"2007","unstructured":"Hirose, A. et al. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 45, 1375\u20131381 (2007).","journal-title":"Hepatology"},{"key":"2569_CR85","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jhep.2009.01.018","volume":"50","author":"Y Nabeshima","year":"2009","unstructured":"Nabeshima, Y., Tazuma, S., Kanno, K., Hyogo, H. & Chayama, K. Deletion of angiotensin II type I receptor reduces hepatic steatosis. J. Hepatol. 50, 1226\u20131235 (2009).","journal-title":"J. Hepatol."},{"key":"2569_CR86","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/jhep.2001.28231","volume":"34","author":"H Yoshiji","year":"2001","unstructured":"Yoshiji, H. et al. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34, 745\u2013750 (2001).","journal-title":"Hepatology"},{"key":"2569_CR87","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/brain\/awt202","volume":"137","author":"R Fu","year":"2014","unstructured":"Fu, R. et al. Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain 137, 1282\u20131303 (2014).","journal-title":"Brain"},{"key":"2569_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1571","volume":"9","author":"Y Fang","year":"2021","unstructured":"Fang, Y., Chen, H., Chen, Q., Wang, C. & Liang, L. Compound hemizygous variants in SERPINA7 gene cause thyroxine-binding globulin deficiency. Mol. Genet. Genom. Med. 9, e1571 (2021).","journal-title":"Mol. Genet. Genom. Med."},{"key":"2569_CR89","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.hbpd.2023.08.009","volume":"22","author":"A Bhattacharya","year":"2023","unstructured":"Bhattacharya, A., Taylor, R. E. & Guo, G. L. In vivo mouse models to study bile acid synthesis and signaling. Hepatobiliary Pancreat. Dis. Int. 22, 466\u2013473 (2023).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"2569_CR90","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1210\/en.2011-2160","volume":"153","author":"A Crudo","year":"2012","unstructured":"Crudo, A. et al. Prenatal synthetic glucocorticoid treatment changes DNA methylation states in male organ systems: multigenerational effects. Endocrinology 153, 3269\u20133283 (2012).","journal-title":"Endocrinology"},{"key":"2569_CR91","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrendo.2014.73","volume":"10","author":"VG Moisiadis","year":"2014","unstructured":"Moisiadis, V. G. & Matthews, S. G. Glucocorticoids and fetal programming part 1: Outcomes. Nat. Rev. Endocrinol. 10, 391\u2013402 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2569_CR92","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrendo.2014.74","volume":"10","author":"VG Moisiadis","year":"2014","unstructured":"Moisiadis, V. G. & Matthews, S. G. Glucocorticoids and fetal programming part 2: Mechanisms. Nat. Rev. Endocrinol. 10, 403\u2013411 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2569_CR93","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1093\/hmg\/ddt182","volume":"22","author":"EA Rog-Zielinska","year":"2013","unstructured":"Rog-Zielinska, E. A. et al. Glucocorticoid receptor is required for fetal heart maturation. Hum. Mol. Genet. 22, 3269\u20133282 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"2569_CR94","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1210\/me.2003-0283","volume":"18","author":"C Opherk","year":"2004","unstructured":"Opherk, C. et al. Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Mol. Endocrinol. 18, 1346\u20131353 (2004).","journal-title":"Mol. Endocrinol."},{"key":"2569_CR95","doi-asserted-by":"publisher","first-page":"152308","DOI":"10.1016\/j.tox.2019.152308","volume":"428","author":"Y Chen","year":"2019","unstructured":"Chen, Y., He, Z., Chen, G., Liu, M. & Wang, H. Prenatal glucocorticoids exposure and fetal adrenal developmental programming. Toxicology 428, 152308 (2019).","journal-title":"Toxicology"},{"key":"2569_CR96","doi-asserted-by":"publisher","first-page":"9138","DOI":"10.3390\/ijms22179138","volume":"22","author":"S Ishii","year":"2021","unstructured":"Ishii, S. The role of histone deacetylase 3 complex in nuclear hormone receptor action. Int. J. Mol. Sci. 22, 9138 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2569_CR97","doi-asserted-by":"publisher","first-page":"1190094","DOI":"10.3389\/fmolb.2023.1190094","volume":"10","author":"H Paluvai","year":"2023","unstructured":"Paluvai, H., Shanmukha, K. D., Tyedmers, J. & Backs, J. Insights into the function of HDAC3 and NCoR1\/NCoR2 corepressor complex in metabolic diseases. Front. Mol. Biosci. 10, 1190094 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"2569_CR98","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/2159-8290.CD-19-0116","volume":"10","author":"P Mondello","year":"2020","unstructured":"Mondello, P. et al. Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma. Cancer Discov. 10, 440\u2013459 (2020).","journal-title":"Cancer Discov."},{"key":"2569_CR99","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1158\/2767-9764.CRC-22-0255","volume":"2","author":"L Maneix","year":"2022","unstructured":"Maneix, L. et al. Proteasome inhibitors silence oncogenes in multiple myeloma through localized histone deacetylase 3 (HDAC3) stabilization and chromatin condensation. Cancer Res. Commun. 2, 1693\u20131710 (2022).","journal-title":"Cancer Res. Commun."},{"key":"2569_CR100","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1016\/j.molcel.2023.08.029","volume":"83","author":"Y Abe","year":"2023","unstructured":"Abe, Y. et al. RANK ligand converts the NCoR\/HDAC3 corepressor to a PGC1\u03b2- and RNA-dependent co-activator of osteoclast gene expression. Mol. Cell 83, 3421\u20133437.e3411 (2023).","journal-title":"Mol. Cell"},{"key":"2569_CR101","doi-asserted-by":"publisher","first-page":"109878","DOI":"10.1016\/j.abb.2023.109878","volume":"752","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Mechanism by which HDAC3 regulates manganese induced H3K27ac in SH-SY5Y cells and intervention by curcumin. Arch. Biochem. Biophys. 752, 109878 (2024).","journal-title":"Arch. Biochem. Biophys."},{"key":"2569_CR102","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1158\/0008-5472.CAN-16-2100","volume":"76","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. CBX4 suppresses metastasis via recruitment of HDAC3 to the Runx2 promoter in colorectal carcinoma. Cancer Res. 76, 7277\u20137289 (2016).","journal-title":"Cancer Res."},{"key":"2569_CR103","doi-asserted-by":"publisher","first-page":"154095","DOI":"10.1016\/j.scitotenv.2022.154095","volume":"826","author":"Y Dai","year":"2022","unstructured":"Dai, Y. et al. Prenatal dexamethasone exposure induced pancreatic \u03b2-cell dysfunction and glucose intolerance of male offspring rats: role of the epigenetic repression of ACE2. Sci. Total Environ. 826, 154095 (2022).","journal-title":"Sci. Total Environ."},{"key":"2569_CR104","doi-asserted-by":"publisher","first-page":"158524","DOI":"10.1016\/j.bbalip.2019.158524","volume":"1864","author":"W Huang","year":"2019","unstructured":"Huang, W., Zhou, J., Zhang, G., Zhang, Y. & Wang, H. Decreased H3K9 acetylation level of LXR\u03b1 mediated dexamethasone-induced placental cholesterol transport dysfunction. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1864, 158524 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"2569_CR105","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.eehl.2024.04.008","volume":"3","author":"X Sui","year":"2024","unstructured":"Sui, X. et al. Prenatal ozone exposure is associated with children overweight and obesity: evidence from the Shanghai Maternal-Child Pairs Cohort. Eco Environ. Health 3, 436\u2013444 (2024).","journal-title":"Eco Environ. Health"},{"key":"2569_CR106","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.eehl.2024.01.007","volume":"3","author":"H Gao","year":"2024","unstructured":"Gao, H. et al. Associating prenatal phthalate exposure with childhood autistic traits: investigating potential adverse outcome pathways and the modifying effects of maternal vitamin D. Eco Environ. Health 3, 425\u2013435 (2024).","journal-title":"Eco Environ. Health"},{"key":"2569_CR107","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0000000000000054","volume":"26","author":"BL Bermas","year":"2014","unstructured":"Bermas, B. L. Nonsteroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy. Curr. Opin. Rheumatol. 26, 334\u2013340 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"2569_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115578","volume":"141","author":"H Xiao","year":"2020","unstructured":"Xiao, H. et al. Lentivirus-delivered ACE siRNA rescues the impaired peak bone mass accumulation caused by prenatal dexamethasone exposure in male offspring rats. Bone 141, 115578 (2020).","journal-title":"Bone"},{"key":"2569_CR109","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13293-022-00459-7","volume":"13","author":"AE Braun","year":"2022","unstructured":"Braun, A. E. et al. Sex at the interface: the origin and impact of sex differences in the developing human placenta. Biol. Sex Differ. 13, 50 (2022).","journal-title":"Biol. Sex Differ."},{"key":"2569_CR110","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1042\/CS20150611","volume":"130","author":"JH Dasinger","year":"2016","unstructured":"Dasinger, J. H. & Alexander, B. T. Gender differences in developmental programming of cardiovascular diseases. Clin. Sci. 130, 337\u2013348 (2016).","journal-title":"Clin. Sci."},{"key":"2569_CR111","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.envres.2006.10.003","volume":"104","author":"AM Cummings","year":"2007","unstructured":"Cummings, A. M., Stoker, T. & Kavlock, R. J. Gender-based differences in endocrine and reproductive toxicity. Environ. Res. 104, 96\u2013107 (2007).","journal-title":"Environ. Res."},{"key":"2569_CR112","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.3390\/nu15102335","volume":"15","author":"A Dolce","year":"2023","unstructured":"Dolce, A. & Della Torre, S. Sex, nutrition, and NAFLD: relevance of environmental pollution. Nutrients 15, 2335 (2023).","journal-title":"Nutrients"},{"key":"2569_CR113","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1542\/peds.2004-1832","volume":"115","author":"JB Schwimmer","year":"2005","unstructured":"Schwimmer, J. B., McGreal, N., Deutsch, R., Finegold, M. J. & Lavine, J. E. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 115, e561\u2013e565 (2005).","journal-title":"Pediatrics"},{"key":"2569_CR114","doi-asserted-by":"publisher","first-page":"114979","DOI":"10.1016\/j.taap.2020.114979","volume":"395","author":"L Li","year":"2020","unstructured":"Li, L. et al. miR-148a\/LDLR mediates hypercholesterolemia induced by prenatal dexamethasone exposure in male offspring rats. Toxicol. Appl. Pharmacol. 395, 114979 (2020).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2569_CR115","doi-asserted-by":"publisher","first-page":"115306","DOI":"10.1016\/j.bcp.2022.115306","volume":"206","author":"X Li","year":"2022","unstructured":"Li, X. et al. MiR-133a-3p\/Sirt1 epigenetic programming mediates hypercholesterolemia susceptibility in female offspring induced by prenatal dexamethasone exposure. Biochem. Pharmacol. 206, 115306 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2569_CR116","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.taap.2018.05.005","volume":"351","author":"Z Chen","year":"2018","unstructured":"Chen, Z. et al. Course-, dose-, and stage-dependent toxic effects of prenatal dexamethasone exposure on long bone development in fetal mice. Toxicol. Appl. Pharmacol. 351, 12\u201320 (2018).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2569_CR117","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.steroids.2016.08.006","volume":"115","author":"YL Tain","year":"2016","unstructured":"Tain, Y. L., Wu, M. S. & Lin, Y. J. Sex differences in renal transcriptome and programmed hypertension in offspring exposed to prenatal dexamethasone. Steroids 115, 40\u201346 (2016).","journal-title":"Steroids"},{"key":"2569_CR118","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/01.HYP.0000049763.51269.51","volume":"41","author":"LA Ortiz","year":"2003","unstructured":"Ortiz, L. A., Quan, A., Zarzar, F., Weinberg, A. & Baum, M. Prenatal dexamethasone programs hypertension and renal injury in the rat. Hypertension 41, 328\u2013334 (2003).","journal-title":"Hypertension"},{"key":"2569_CR119","doi-asserted-by":"publisher","first-page":"E863","DOI":"10.1152\/ajpendo.00137.2004","volume":"287","author":"D O\u2019Regan","year":"2004","unstructured":"O\u2019Regan, D., Kenyon, C. J., Seckl, J. R. & Holmes, M. C. Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology. Am. J. Physiol. Endocrinol. Metab. 287, E863\u2013E870 (2004).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2569_CR120","doi-asserted-by":"publisher","first-page":"e0221719","DOI":"10.1371\/journal.pone.0221719","volume":"14","author":"S Khurana","year":"2019","unstructured":"Khurana, S. et al. Fetal programming of adrenal PNMT and hypertension by glucocorticoids in WKY rats is dose and sex dependent. PLoS ONE 14, e0221719\u2013e0221719 (2019).","journal-title":"PLoS ONE"},{"key":"2569_CR121","doi-asserted-by":"publisher","first-page":"e14154","DOI":"10.14814\/phy2.14154","volume":"7","author":"J Jain","year":"2019","unstructured":"Jain, J., Legan, S. K., Alhamoud, I., Gattineni, J. & Baum, M. Effect of sex on glomerular filtration rate in programmed rats by prenatal dexamethasone. Physiol. Rep. 7, e14154\u2013e14154 (2019).","journal-title":"Physiol. Rep."},{"key":"2569_CR122","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1177\/15353702211003294","volume":"246","author":"I Alhamoud","year":"2021","unstructured":"Alhamoud, I., Legan, S. K., Gattineni, J. & Baum, M. Sex differences in prenatal programming of hypertension by dexamethasone. Exp. Biol. Med. 246, 1554\u20131562 (2021).","journal-title":"Exp. Biol. Med."},{"key":"2569_CR123","doi-asserted-by":"publisher","first-page":"105942","DOI":"10.1016\/j.phrs.2021.105942","volume":"174","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Sex difference in adrenal developmental toxicity induced by dexamethasone and its intrauterine programming mechanism. Pharmacol. Res. 174, 105942 (2021).","journal-title":"Pharmacol. Res."},{"key":"2569_CR124","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1021\/acs.jafc.0c06748","volume":"69","author":"Y Dai","year":"2021","unstructured":"Dai, Y. et al. Prenatal exposure to retrorsine induces developmental toxicity and hepatotoxicity of fetal rats in a sex-dependent manner: the role of pregnane X receptor activation. J. Agric. Food Chem. 69, 3219\u20133231 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"2569_CR125","doi-asserted-by":"publisher","first-page":"115137","DOI":"10.1016\/j.taap.2020.115137","volume":"406","author":"E Xiang","year":"2020","unstructured":"Xiang, E. et al. Female-specific activation of pregnane X receptor mediates sex difference in fetal hepatotoxicity by prenatal monocrotaline exposure. Toxicol. Appl. Pharmacol. 406, 115137 (2020).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2569_CR126","doi-asserted-by":"publisher","first-page":"115187","DOI":"10.1016\/j.taap.2020.115187","volume":"404","author":"H Kou","year":"2020","unstructured":"Kou, H., Gui, S., Dai, Y., Guo, Y. & Wang, H. Epigenetic repression of AT2 receptor is involved in \u03b2 cell dysfunction and glucose intolerance of adult female offspring rats exposed to dexamethasone prenatally. Toxicol. Appl. Pharmacol. 404, 115187 (2020).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2569_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202510277","volume":"12","author":"Y Dai","year":"2025","unstructured":"Dai, Y. et al. Mechanisms and pathophysiological significance of insulin resistance in offspring with intrauterine growth restriction mediated by hepatic GR\/miR-1224 programming. Adv Sci. 12, e10277 (2025).","journal-title":"Adv Sci."},{"key":"2569_CR128","doi-asserted-by":"publisher","first-page":"9250711","DOI":"10.26599\/FSHW.2025.9250711","volume":"14","author":"S Gui","year":"2025","unstructured":"Gui, S., Guo, X., Dai, Y., Kou, H. & Wang, H. Glucocorticoid-insulin like growth factor 1 axis programming might be involved in pancreatic \u03b2-cell dysplasia and dysfunction in female offspring rats exposed to caffeine prenatally. Food Sci. Hum. Wellness 14, 9250711 (2025).","journal-title":"Food Sci. Hum. Wellness"},{"key":"2569_CR129","doi-asserted-by":"publisher","first-page":"164929","DOI":"10.1016\/j.scitotenv.2023.164929","volume":"894","author":"Y Dai","year":"2023","unstructured":"Dai, Y. et al. Lactational retrorsine exposure changes maternal milk components and disturbs metabolism homeostasis of offspring rats. Sci. Total Environ. 894, 164929 (2023).","journal-title":"Sci. Total Environ."},{"key":"2569_CR130","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"2569_CR131","first-page":"491","volume":"39","author":"A Tian","year":"2023","unstructured":"Tian, A. & Yang, Y. Diagnosis of nonalcoholic fatty liver disease: the importance of pathology. J. Clin. Hepatol. 39, 491\u2013497 (2023).","journal-title":"J. Clin. Hepatol."},{"key":"2569_CR132","doi-asserted-by":"publisher","first-page":"qzaf072","DOI":"10.1093\/gpbjnl\/qzaf072","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang, S. et al. The GSA family in 2025: a broadened sharing platform for multi-omics and multimodal data. Genom. Proteom. Bioinform. 23, qzaf072 (2025).","journal-title":"Genom. Proteom. Bioinform."},{"key":"2569_CR133","unstructured":"CNCB-NGDC Members and Partners Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2025. Nucleic Acids Res. 53, D30-d44 (2025)."},{"key":"2569_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-716","volume":"15","author":"F Gao","year":"2014","unstructured":"Gao, F. et al. Marked methylation changes in intestinal genes during the perinatal period of preterm neonates. BMC Genom. 15, 716 (2014).","journal-title":"BMC Genom."},{"key":"2569_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0121-1","volume":"7","author":"F Gao","year":"2015","unstructured":"Gao, F. et al. Global analysis of DNA methylation in hepatocellular carcinoma by a liquid hybridization capture-based bisulfite sequencing approach. Clin. Epigenetics 7, 86 (2015).","journal-title":"Clin. Epigenetics"},{"key":"2569_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0533-9","volume":"15","author":"F Gao","year":"2014","unstructured":"Gao, F. et al. Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMES in human hepatocellular carcinoma. Genome Biol. 15, 533 (2014).","journal-title":"Genome Biol."},{"key":"2569_CR137","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/dnares\/dsy001","volume":"25","author":"X Pan","year":"2018","unstructured":"Pan, X. et al. Early microbial colonization affects DNA methylation of genes related to intestinal immunity and metabolism in preterm pigs. DNA Res. 25, 287\u2013296 (2018).","journal-title":"DNA Res."},{"key":"2569_CR138","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jes.2023.02.021","volume":"137","author":"Y Dai","year":"2024","unstructured":"Dai, Y., Peng, Y., Hu, W., Liu, Y. & Wang, H. Prenatal amoxicillin exposure induces developmental toxicity in fetal mice and its characteristics. J. Environ. Sci. 137, 287\u2013301 (2024).","journal-title":"J. Environ. Sci."},{"key":"2569_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2018.06.005","volume":"408","author":"M Liu","year":"2018","unstructured":"Liu, M. et al. Decreased H3K9ac level of StAR mediated testicular dysplasia induced by prenatal dexamethasone exposure in male offspring rats. Toxicology 408, 1\u201310 (2018).","journal-title":"Toxicology"},{"key":"2569_CR140","doi-asserted-by":"crossref","unstructured":"Sun, X. et al. The pivotal role of GR-CAR pathway in fetal programming of hepatic cytochrome P450 3A alteration in adulthood. Adv. Sci. 16, e15583 (2025).","DOI":"10.1002\/advs.202515583"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02569-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:02:53Z","timestamp":1771401773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02569-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2569"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02569-1","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}